Business Wire

Mavenir Announces Industry’s Most Advanced Network Security and Fraud Management Suite

Del

Mavenir, focused on transforming mobile network economics for Communications Service Providers (CSPs), today announced its Network Security and Fraud Management Suite including a Fraud Management System equipped with big data analytics and advanced AI techniques such as machine learning and deep learning.

As operators continue to roll out new LTE-based services, Diameter signaling has become a new target for malicious attacks. Location tracking, interception of voice and text messages, denial of service on network and subscriber level, and other unauthorized activities are all potential use cases leading to fraudulent outcome that have occurred in the past with the SS7 protocol targeting 2G / 3G networks, and are also applicable to 4G networks, according to a recent report from the FCC’s Communications Security, Reliability and Interoperability Council (CSRIC).

Where security is compromised, fraud is inevitable. Traditional systems can no longer keep pace with the volume and velocity of criminal activity. Many existing systems can’t uncover new fraud types; they overwhelm the user with false positives or use dated rules that only uncover fraud long after it has taken place. Furthermore, the most impacting types and methods of fraud are related to subscription fraud, PBX hacking, international revenue share fraud, interconnect bypass, premium rate service.

Mavenir’s Security and Fraud Management Suite protects the network in real-time, and with predictive analytics and machine learning, the network is protected even as new vulnerabilities arise. Mavenir distinguishes between three main verticals within the fraud and security domain while providing the following corresponding solutions:

  • Messaging Revenue Assurance: Protects the CSPs’ revenue leakage based on innovative bypass techniques for A2P traffic. It offers efficient real-time detection of SPAM campaigns acknowledged by CSPs around the globe.
  • Network Signaling Security: Provides Signaling Firewalling solutions that implement the GSMA mitigation recommendations (FS.11 and FS.19) to detect and prevent the signaling-based attacks from happening.
  • Fraud Management: A modern data approach to fight fraud in real time. As part of its Security and Fraud Management Suite, Mavenir provides the Fraud Management Solution based on Big Data approach suited to manage the volume, velocity, and variety of structured and unstructured data over wireless networks. It relies on a unique, real-time fraud analytics platform, tailored for CSPs’ most pressing needs.

The key features of Mavenir’s Network Security and Fraud Management Suite include:

  • Easy-to-use / intuitive management interface for minimal response times to act on any unforeseen ongoing suspicious activity detected through sophisticated mitigation algorithms.
  • Powerful correlation engine offers detection of anomalous traffic patterns through efficient traffic profiling capabilities. The machine learning mechanisms behind the correlation engine create challenging obstacles for fraudulent activities to pass through unnoticed.
  • Supporting Analytics component enables CSPs to create interactive dashboards based on any required key performance indicators. The generated reports offer insights on the signaling traffic beyond security context helping the operators reveal any possible network optimizations or revise their interworking agreements.

“Malicious attacks are evolving with technology at a rapid pace and take revenue from operators. As a recent CFCA survey1 shows, global fraud levels translate into $29.2 billion global revenue loss for CSPs. Without sophisticated, adaptable, and self-learning security solutions, operators will forever be behind the technology curve with unprotected revenues,” said Pardeep Kohli, President and CEO of Mavenir. “We provide advanced cloud-native security for every type of messaging and signaling protocol used in the Telecom environment with anti-spam, anti-fraud solutions and firewall products.”

Mavenir’s cloud-native Security Suite includes Messaging (SMS, MMS, and RCS) Spam and Fraud control, Equipment Identity Register (EIR), Signaling Firewall (Diameter, SIP, SS7 and GTP), Session Border Controller (vSBC) and Mobile Edge Gateway (including ePDG, SeGW, and HeNB-GW) enabling operators to understand, monitor, enforce and maintain network security. The security suite fully covers protection of the core mobile network including the messaging revenue of modern CSPs.

Mavenir’s AI Center of Excellence is based in Brno, Czech Republic.

Visit Mavenir at 5G World in London from June 12th – 14th, 2018.

About Mavenir:

Mavenir is purpose-built to redefine mobile network economics for Communication Service Providers (CSPs). Our innovative solutions pave the way to 5G with 100% software-based, end-to-end, Cloud Native network solutions. Leveraging industry-leading firsts in VoLTE, VoWiFi, Advanced Messaging (RCS), Multi-ID, vEPC and Cloud RAN, Mavenir accelerates network transformation for more than 250+ CSP customers in over 130 countries, serving over 50% of the world’s subscribers.

We embrace disruptive, innovative technology architectures and business models that drive service agility, flexibility, and velocity. With solutions that propel NFV evolution to achieve web-scale economics, Mavenir offers solutions to help CSPs with cost reduction, revenue generation and revenue protection. Learn more at mavenir.com.

 
Mavenir, the M logo, and Cloud Range are trademarks owned by Mavenir Systems, Inc.
Copyright © 2017 Mavenir Systems, Inc. All Rights Reserved.
 

 

1   CFCA Global Fraud Loss Survey for 2017

Contact information

Mavenir
Maryvonne Tubb
PR@mavenir.com
or
MatterNow
Lydia Fakhouri
mavenir@matternow.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

XINHUANET: Promotion Event of The Most Beautiful Shooting Location in China Held During Cannes Film Festival25.5.2019 18:20:00 CESTPressemelding

On May 16 (local time), an event was held at the 72nd Cannes Film Festival to recommend China’s most beautiful shooting locations on the theme of “Fascinating China.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190525005008/en/ The representative from Cannes Convention Bureau (1st L), Michel Chevillon (C), vice president of the French Riviera Chamber of Commerce and Industry and head of hotel association, and Adeline CHAUVEAU (3rd R), officer in charge of film and television projects from French Embassy to China, pose for a group photo with the representatives from the cities awarded for "The most beautiful shooting location in China." (Photo: Business Wire) In the event, the Yellow Sea National Forest Park in Dongtai, Jiangsu Province, the One Hundred Mile Azalea Forest in Bijie, Guizhou Province, Siming District of Xiamen, Fujian Province, and the Li Autonomous County in Lingshui, Hainan Province were on the list. The p

Knopp Biosciences Presents Positive Preclinical Data for Lead Neonatal Epilepsy Drug Candidate at 2019 Antiepileptic Drug and Device Trials XV Conference24.5.2019 14:00:00 CESTPressemelding

Knopp Biosciences LLC, a privately held drug discovery and development company focused on delivering breakthrough treatments for inflammatory and neurological diseases of high unmet need, today presented in vitro and in vivo data for the company’s lead molecule for the targeted treatment of KCNQ2-neonatal epileptic encephalopathy (KCNQ2-NEE) at the Antiepileptic Drug and Device Trials XV Conference in Miami, Florida. KCNQ2-NEE, a rare infant genetic epilepsy, results from mutations in genes encoding the Kv7.2/Kv7.3 ion channel, leading to frequent seizures and profound developmental delay. The preclinical data were presented by Steven Dworetzky, Ph.D., Knopp’s Chief Scientific Officer, a longtime Kv7 researcher who led the group that first cloned the Kv7.2 and Kv7.3 genes during his former tenure with the Bristol-Myers Squibb Co. Dr. Dworetzky presented results demonstrating the in vitro nanomolar activity of KB-3061 and its significant seizure protection in the maximal electroshock mo

Accelerate Your Business in South Korea Through 2019 K-Startup Grand Challenge24.5.2019 10:20:00 CESTPressemelding

Entrepreneurs from across the globe should set their sights on participating in the 2019 K-Startup Grand Challenge. Supported by the Ministry of SMEs and Startups and National IT Industry Promotion Agency (NIPA) of South Korea, the initiative provides invaluable support and comprehensive resources to early age startups. Applications for the K-Startup Grand Challenge are currently being accepted through June 14, 2019. In order to advance in the program, teams must pass a regional audition. A judging panel of startup ecosystem experts and Korean accelerators will select 40 teams to participate in an enriching 3.5 month-long acceleration program in Korea. The selected teams will have exclusive access to free office space at the Startup Campus in Pangyo Techno Valley, one-on-one mentoring, information sessions, coaching on Korean and Asian business culture and the chance to attend insightful seminars on accounting regulations to tax laws, patents and more. Opportunities for networking with

New Investigational Clinical Data for Ipsen’s Oncology Products in 11 Solid Tumor Types to Be Presented at 2019 ASCO Annual Meeting24.5.2019 05:00:00 CESTPressemelding

Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that new data from clinical studies on investigational uses of cancer medicines cabozantinib (Cabometyx®), liposomal irinotecan (Onivyde®), and lanreotide autogel (Somatuline®, marketed as Somatuline Depot® in the United States) will be presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting. The meeting takes place in Chicago, Illinois, U.S., 31 May–4 June 2019; data featuring Ipsen medicines includes: New data from the Phase 3 CELESTIAL trial on the association of adverse events with efficacy outcomes for cabozantinib in patients with advanced hepatocellular carcinoma Overview of the Phase 3 COSMIC-312 trial of cabozantinib in combination with atezolizumab vs sorafenib in patients with advanced hepatocellular carcinoma who have not received previous systemic anticancer therapy First Phase 2 data from the CaboGIST study (trial 1317) from the European Organization for Research and Treatment of

The Posiflex Group Showcases an Ecosystem of Connected Solution Endpoints with IoT Remote Monitoring at Computex 201924.5.2019 01:00:00 CESTPressemelding

For the Computex 2019 show, The Posiflex Group is featuring leading solution technology from the family of brands as a fully Serviced IoT Ecosystem. Solution end points include: Connected Modular Kiosks, POS Terminals, and Digital Signage solutions from Posiflex and KIOSK Information Systems Smart Medical Displays with gesture controls from Portwell Connected Gaming Solutions with Player Tracking Technology from Portwell subsidiary, Ganlot The booth display is based on common field service endpoints represented in a European Manor Destination Resort setting. Field solutions for an array of vertical market applications include QSR ordering, cinema ticketing, fashion retail customer loyalty, interactive signage, hotel / medical center check-in and bill pay, as well as casino gaming technology. This year, in addition to their renowned POS product suite, Posiflex will be featuring newly introduced Modular Kiosk platforms (co-designed by KIOSK and Posiflex), which are configure-to-order sta

Audi China President Thomas Owsianski to Keynote at CES Asia 201923.5.2019 20:00:00 CESTPressemelding

The Consumer Technology Association (CTA)TM today announced that Thomas Owsianski, president of Audi China, will deliver a keynote address at the upcoming CES Asia 2019. Now in its fifth year, CES Asia will run June 11-13, 2019 at the Shanghai New International Expo Centre (SNIEC) in Shanghai, China. Thomas Owsianski’s keynote is scheduled for 4 PM, Tuesday, June 11, where he will unveil Audi’s vision in transforming mobility from a driving experience to a digital adventure. Mr. Owsianski joined the top management team of Audi China in August 2018 and was named President in October 2018. “Audi has been at the forefront of driving global transformation in the automotive industry through their breakthrough advancements in technology,” said Karen Chupka, executive vice president, CES. “Innovation has revolutionized the transportation experience, and we welcome Mr. Owsianski to the CES Asia stage to share Audi’s vision for the future of global mobility.” Throughout Asia and beyond, technol